Pro-MMP-9 upregulation in HT1080 cells expressing CD9 is regulated by epidermal growth factor receptor

Biochemical and Biophysical Research Communications

Volumn 442, Issue 1-2, 2013, Pages 99-104

  Herr, Michael J ^a,b   Mabry, Scott E ^a   Jameson, Jessica F ^a,c   Jennings, Lisa K ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Microbiology Biochemistry and Immunology   (United States)

^c CHRISTIAN BROTHERS UNIVERSITY   (United States)

Author keywords

CD9; Cell invasion; Epidermal growth factor receptor; Matrix metalloproteinase; MMP 9; Tetraspanin

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CD9 ANTIGEN; CYCLOPHILIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; GELATINASE B; LAPATINIB; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SUNITINIB;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL SURFACE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSARCOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

CD9; CELL INVASION; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MMP-9; TETRASPANIN;

ANTIGENS, CD9; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION;

EID: 84889641516     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.11.021     Document Type: Article

References (29)

1. S. Zucker, J. Cao, and W.T. Chen Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment Oncogene 19 2000 6642 6650
2. D.R. Close Matrix metalloproteinase inhibitors in rheumatic diseases Ann Rheum Dis 60 Suppl. 3 2001 iii62 iii67
3. J.W. Skiles, N.C. Gonnella, and A.Y. Jeng The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors Curr. Med. Chem. 11 2004 2911 2977
4. M.J. Herr, J. Kotha, N. Hagedorn, B. Smith, and L.K. Jennings Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9 PLoS ONE 8 2013 e67766
5. M.E. Hemler Tetraspanin functions and associated microdomains Nat. Rev. Mol. Cell Biol. 6 2005 801 811
6. T. Sakuma, S. Higashiyama, S. Hosoe, S. Hayashi, and N. Taniguchi CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain J. Biochem. 122 1997 474 480
7. K. Nakamura, T. Mitamura, T. Takahashi, T. Kobayashi, and E. Mekada Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity J. Biol. Chem. 275 2000 18284 18290
8. A.R. Shaw, A. Domanska, A. Mak, A. Gilchrist, K. Dobler, L. Visser, S. Poppema, L. Fliegel, M. Letarte, and B.J. Willett Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation J. Biol. Chem. 270 1995 24092 24099
9. C.M. Longhurst, J.D. Jacobs, M.M. White, J.T. Crossno Jr., D.A. Fitzgerald, J. Bao, T.J. Fitzgerald, R. Raghow, and L.K. Jennings Chinese hamster ovary cell motility to fibronectin is modulated by the second extracellular loop of CD9. Identification of a putative fibronectin binding site J. Biol. Chem. 277 2002 32445 32452
10. G.A. Cook, D.A. Wilkinson, J.T. Crossno Jr., R. Raghow, and L.K. Jennings The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin Exp. Cell Res. 251 1999 356 371
11. E. Rubinstein, V. Poindessous-Jazat, F. Le Naour, M. Billard, and C. Boucheix CD9, but not other tetraspans, associates with the beta1 integrin precursor Eur. J. Immunol. 27 1997 1919 1927
12. W. Shi, H. Fan, L. Shum, and R. Derynck The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation J. Cell Biol. 148 2000 591 602
13. Y. Murayama, Y. Shinomura, K. Oritani, J. Miyagawa, H. Yoshida, M. Nishida, F. Katsube, M. Shiraga, T. Miyazaki, T. Nakamoto, S. Tsutsui, S. Tamura, S. Higashiyama, I. Shimomura, and N. Hayashi The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells J. Cell. Physiol. 216 2008 135 143
14. S. Kohmo, T. Kijima, Y. Otani, M. Mori, T. Minami, R. Takahashi, I. Nagatomo, Y. Takeda, H. Kida, S. Goya, M. Yoshida, T. Kumagai, I. Tachibana, S. Yokota, and I. Kawase Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer Cancer Res. 70 2010 8025 8035
15. J.R. Hwang, K. Jo, Y. Lee, B.J. Sung, Y.W. Park, and J.H. Lee Upregulation of CD9 in ovarian cancer is related to the induction of TNF-alpha gene expression and constitutive NF-kappaB activation Carcinogenesis 33 2012 77 83
16. S. Chen, Y. Sun, Z. Jin, and X. Jing Functional and biochemical studies of CD9 in fibrosarcoma cell line Mol. Cell. Biochem. 350 2011 89 99
17. G. Cox, J.L. Jones, and K.J. O'Byrne Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin. Cancer Res. 6 2000 2349 2355
18. Q. Qiu, M. Yang, B.K. Tsang, and A. Gruslin EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways Reproduction 128 2004 355 363
19. D. Toda, T. Ota, K. Tsukuda, K. Watanabe, T. Fujiyama, M. Murakami, M. Naito, and N. Shimizu Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells Anticancer Res. 26 2006 129 134
20. S. Kim, J.H. Choi, H.I. Lim, S.K. Lee, W.W. Kim, S. Cho, J.S. Kim, J.H. Kim, J.H. Choe, S.J. Nam, J.E. Lee, and J.H. Yang EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line Cell. Signal. 21 2009 892 898
21. L.K. Jennings, C.F. Fox, W.C. Kouns, C.P. McKay, L.R. Ballou, and H.E. Schultz The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies J. Biol. Chem. 265 1990 3815 3822
22. C.W. Lee, C.C. Lin, W.N. Lin, K.C. Liang, S.F. Luo, C.B. Wu, S.W. Wang, and C.M. Yang TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 292 2007 L799 L812
23. J.H. Zuo, W. Zhu, M.Y. Li, X.H. Li, H. Yi, G.Q. Zeng, X.X. Wan, Q.Y. He, J.H. Li, J.Q. Qu, Y. Chen, and Z.Q. Xiao Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin J. Cell. Biochem. 112 2011 2508 2517
24. J.C. Cheng, C.H. Chou, M.L. Kuo, and C.Y. Hsieh Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway Oncogene 25 2006 7009 7018
25. S.K. Kuwada, and X. Li Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation Mol. Biol. Cell 11 2000 2485 2496
26. J. Kotha, C. Longhurst, W. Appling, and L.K. Jennings Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway Exp. Cell Res. 314 2008 1811 1822
27. J. Kotha, C. Zhang, C.M. Longhurst, Y. Lu, J. Jacobs, Y. Cheng, and L.K. Jennings Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasia Atherosclerosis 203 2009 377 386
28. M. Higashiyama, T. Taki, Y. Ieki, M. Adachi, C.L. Huang, T. Koh, K. Kodama, O. Doi, and M. Miyake Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer Cancer Res. 55 1995 6040 6044
29. M. Adachi, T. Taki, T. Konishi, C.I. Huang, M. Higashiyama, and M. Miyake Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression J. Clin. Oncol. 16 1998 1397 1406